Nasus Pharma Ltd. (NSRX) — Financial Flexibility Index
Nasus Pharma Ltd. (NSRX) has a Financial Flexibility Index of -2.19x as of December 2025. Free cash flow of $-4.90 Million (operating CF $-4.92 Million minus capex $14.00K) represents -2% of total liabilities ($2.24 Million). Check Nasus Pharma Ltd. (NSRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nasus Pharma Ltd. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Nasus Pharma Ltd. across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Nasus Pharma Ltd..
Annual Financial Flexibility Index for Nasus Pharma Ltd. (2022–2025)
Year-by-year free cash flow to debt coverage for Nasus Pharma Ltd.. Explore how well can Nasus Pharma Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.19x | $-4.90 Million | $-4.92 Million | $2.24 Million | ▼ -1195.8% |
| 2024 | -0.17x | $-665.00K | $-665.00K | $3.93 Million | ▲ +30.2% |
| 2023 | -0.24x | $-1.03 Million | $-1.03 Million | $4.24 Million | ▲ +35.8% |
| 2022 | -0.38x | $-1.21 Million | $-1.21 Million | $3.20 Million | — |